Virtual Human Twins: Revolutionizing Drug and Device Testing

Virtual Human Twins: Revolutionizing Drug and Device Testing | Elem Biotech Pt1

There are two parts of this interview, in the first session, I dive into Elem and what the company is doing with Christopher Morton. In this exciting episode of Life Science Discussed Podcast, host Don Davis welcomes Christopher...

Show Notes

There are two parts of this interview, in the first session, I dive into Elem and what the company is doing with Christopher Morton.

In this exciting episode of Life Science Discussed Podcast, host Don Davis welcomes Christopher Morton, CEO of Elem Biotech, to talk about the groundbreaking work of virtual human twins in drug and medical device testing. Morton, an aeronautical engineer turned biotech innovator, discusses Elem's platform that allows pharmaceutical companies, medtechs, and CROs to test new therapeutics using virtual human models instead of animal models. They delve into how this approach, distinct from AI-based methods, focuses on mechanistic modeling using MRIs and CT scans to replicate human physiological functions. Morton explains how Elem Biotech's solutions help in precision medicine, clinical trial design, and reducing animal trials, supported by supercomputing power and cloud technology. Tune in to discover how virtual human models are poised to transform life sciences and medical testing.

00:00 Introduction and Welcome

00:43 Christopher Morton's Background

01:57 Introduction to Elem Biotech

02:45 Mechanistic Approach vs. AI Models

03:47 Precision Medicine and Virtual Human Twins

08:58 Supercomputing and Technological Infrastructure

13:07 Applications in Pharma and Medical Devices

21:07 Challenges and Future Directions

25:59 Conclusion and Final Thoughts

Please check out our Life Science Success Resources. You will find tools that will support growing companies and books for authors I have interviewed.